CIK 0001672688
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Absci Corp
Sign in to watch- Ticker
- ABSI
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 853383487
- Phone
- +1 360-949-1041
- Business address
- 18105 SE MILL PLAIN BLVD, VANCOUVER, WA, 98683
- Former names
- AbSci, LLC
- 4 Grant or award Director acquired 8,820 shares (grant or award)
- 4 Grant or award Director acquired 8,820 shares (grant or award)
- 4 Open-market sale 10% owner sold 3,100,000 shares at $4.40 ($13,640,000)
- 4 Grant or award Chief Executive Officer acquired 1,500,000 shares (grant or award)
- 4 Open-market buy Director bought 222,222 shares at $4.50 ($999,999)
- 5 Insider Annual Insider Trading Report
- 4 Grant or award SVP, CAO acquired 20,570 shares (grant or award)
- 4 Grant or award Chief Innovation Officer acquired 83,125 shares (grant or award)
- 4 Grant or award CFO / CBO acquired 114,010 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 182,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CFO / CBO acquired 2,900 shares (grant or award)
- 4 Grant or award SVP, CAO acquired 131,100 shares (grant or award)
- 4 Grant or award Chief Innovation Officer acquired 175,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 175,000 shares (grant or award)
- 4 Grant or award CFO / CBO acquired 250,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 9 · 164 filings